|
WO2020259535A1
(zh)
*
|
2019-06-25 |
2020-12-30 |
南京金斯瑞生物科技有限公司 |
抗cd47/抗tigit双特异抗体及其制备方法和应用
|
|
US12358987B2
(en)
*
|
2019-07-08 |
2025-07-15 |
Nanjing GenScript Biotech Co., Ltd. |
Anti-CD47/anti-PD-1 bispecific antibody, preparation method and use thereof
|
|
KR20240137107A
(ko)
|
2019-07-16 |
2024-09-19 |
길리애드 사이언시즈, 인코포레이티드 |
Hiv 백신, 및 이의 제조 및 사용 방법
|
|
CN114096564A
(zh)
*
|
2019-07-16 |
2022-02-25 |
南京金斯瑞生物科技有限公司 |
抗cd47/抗ctla-4双特异抗体及其制备方法和应用
|
|
CN114206940B
(zh)
*
|
2019-07-23 |
2023-09-22 |
南京金斯瑞生物科技有限公司 |
抗cd47/抗lag-3双特异抗体及其制备方法和应用
|
|
CN112969715B
(zh)
*
|
2019-08-21 |
2022-03-18 |
和铂医药(上海)有限责任公司 |
一种抗cd47抗原结合蛋白及其应用
|
|
PH12022550489A1
(en)
*
|
2019-09-03 |
2022-12-12 |
Akeso Biopharma Inc |
Anti-cd47 monoclonal antibody and use thereof
|
|
ES2973832T3
(es)
|
2019-10-18 |
2024-06-24 |
Forty Seven Inc |
Terapias combinadas para el tratamiento de síndromes mielodisplásicos y leucemia mieloide aguda
|
|
JP2022552748A
(ja)
|
2019-10-31 |
2022-12-19 |
フォーティ セブン， インコーポレイテッド |
抗ｃｄ４７及び抗ｃｄ２０による血液癌の治療
|
|
CA3164623A1
(en)
|
2019-12-17 |
2021-06-24 |
Pfizer Inc. |
Antibodies specific for cd47, pd-l1, and uses thereof
|
|
IL294032A
(en)
|
2019-12-24 |
2022-08-01 |
Carna Biosciences Inc |
Compounds that regulate diacylglycerol kinase
|
|
TWI890283B
(zh)
|
2020-02-14 |
2025-07-11 |
美商基利科學股份有限公司 |
結合ccr8之抗體及融合蛋白及其用途
|
|
CN112679611B
(zh)
*
|
2021-01-18 |
2022-06-10 |
倍而达药业（苏州）有限公司 |
人源化cd47抗体或其抗原结合片段及应用
|
|
CN115916963A
(zh)
|
2020-03-27 |
2023-04-04 |
门德斯有限公司 |
白血病来源的经修饰细胞用于增强过继性细胞治疗的效力的离体用途
|
|
US20240294635A1
(en)
*
|
2020-04-02 |
2024-09-05 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Antigen-binding polypeptide binding to cd47, and use thereof
|
|
TWI869582B
(zh)
*
|
2020-04-10 |
2025-01-11 |
大陸商和記黃埔醫藥（上海）有限公司 |
抗ｃｄ４７抗體及其用途
|
|
EP4171617A1
(en)
|
2020-06-30 |
2023-05-03 |
Mendus B.V. |
Use of leukemia-derived cells in ovarian cancer vaccines
|
|
WO2022010806A1
(en)
*
|
2020-07-06 |
2022-01-13 |
ALX Oncology Inc. |
Methods for reducing the interference of drugs that bind therapeutic targets expressed on blood cells in serological assays
|
|
EP4190813A4
(en)
*
|
2020-07-31 |
2025-02-12 |
Bio-Thera Solutions, Ltd. |
CD47 ANTIBODIES AND THEIR APPLICATION
|
|
WO2022031680A1
(en)
*
|
2020-08-04 |
2022-02-10 |
Exelixis, Inc. |
Cd47 binding agents and uses thereof
|
|
AU2021346729A1
(en)
*
|
2020-09-28 |
2023-05-11 |
Shanghai Henlius Biologics Co., Ltd. |
Anti-cd47 antibodies and methods of use
|
|
KR102757518B1
(ko)
*
|
2020-12-07 |
2025-01-21 |
(주)이노베이션바이오 |
Cd47에 특이적인 항체 및 이의 용도
|
|
US12071481B2
(en)
*
|
2020-12-23 |
2024-08-27 |
D-10 Therapeutics, Inc. |
Anti-CD47 antibodies and uses thereof
|
|
US20250277031A1
(en)
*
|
2021-01-08 |
2025-09-04 |
Beijing Hanmi Pharmaceutical Co., Ltd. |
Antibody specifically binding to cd47 and antigen-binding fragment thereof
|
|
CA3212351A1
(en)
|
2021-03-12 |
2022-09-15 |
Mendus B.V. |
Methods of vaccination and use of cd47 blockade
|
|
TW202302145A
(zh)
|
2021-04-14 |
2023-01-16 |
美商基利科學股份有限公司 |
ＣＤ４７／ＳＩＲＰα結合及ＮＥＤＤ８活化酶Ｅ１調節次單元之共抑制以用於治療癌症
|
|
AU2022299051B2
(en)
|
2021-06-23 |
2025-03-13 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
MX2023014762A
(es)
|
2021-06-23 |
2024-01-15 |
Gilead Sciences Inc |
Compuestos moduladores de diacilglicerol quinasa.
|
|
JP7651018B2
(ja)
|
2021-06-23 |
2025-03-25 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
JP7686091B2
(ja)
|
2021-06-23 |
2025-05-30 |
ギリアード サイエンシーズ， インコーポレイテッド |
ジアシルグリセロールキナーゼ調節化合物
|
|
EP4365197A4
(en)
*
|
2021-06-30 |
2025-05-14 |
Innobation Bio Co., Ltd. |
Humanized antibody specific to CD47 and pharmaceutical composition containing it for the prevention or treatment of CD47-mediated disease
|
|
WO2023006391A1
(en)
*
|
2021-07-30 |
2023-02-02 |
Ludwig-Maximilians-Universität München |
Anti-cd47 antibodies and use thereof
|
|
AU2022375782B2
(en)
|
2021-10-28 |
2026-02-26 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
JP7787991B2
(ja)
|
2021-10-29 |
2025-12-17 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｃｄ７３化合物
|
|
KR20240123836A
(ko)
|
2021-12-22 |
2024-08-14 |
길리애드 사이언시즈, 인코포레이티드 |
이카로스 아연 핑거 패밀리 분해제 및 이의 용도
|
|
US12122764B2
(en)
|
2021-12-22 |
2024-10-22 |
Gilead Sciences, Inc. |
IKAROS zinc finger family degraders and uses thereof
|
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
WO2023178181A1
(en)
|
2022-03-17 |
2023-09-21 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
KR20240165995A
(ko)
|
2022-03-24 |
2024-11-25 |
길리애드 사이언시즈, 인코포레이티드 |
Trop-2 발현 암의 치료를 위한 병용요법
|
|
TWI876305B
(zh)
|
2022-04-05 |
2025-03-11 |
美商基利科學股份有限公司 |
用於治療結腸直腸癌之組合療法
|
|
CR20240451A
(es)
|
2022-04-21 |
2024-12-04 |
Gilead Sciences Inc |
Compuestos de modulación de kras g12d
|
|
TWI859943B
(zh)
*
|
2022-06-21 |
2024-10-21 |
大陸商廣東菲鵬製藥股份有限公司 |
一種含抗cd47抗體或其抗原結合片段的製劑及其製備方法和應用
|
|
KR20250028371A
(ko)
|
2022-07-01 |
2025-02-28 |
길리애드 사이언시즈, 인코포레이티드 |
Cd73 화합물
|
|
CA3259040A1
(en)
|
2022-07-12 |
2024-01-18 |
Gilead Sciences, Inc. |
HIV Immunogenic Polypeptides and Vaccines and Their Uses
|
|
CN115932271A
(zh)
*
|
2022-09-02 |
2023-04-07 |
东曜药业有限公司 |
一种cd47抗体的试剂组合物及其应用
|
|
WO2024064668A1
(en)
|
2022-09-21 |
2024-03-28 |
Gilead Sciences, Inc. |
FOCAL IONIZING RADIATION AND CD47/SIRPα DISRUPTION ANTICANCER COMBINATION THERAPY
|
|
CN119968212A
(zh)
*
|
2022-10-14 |
2025-05-09 |
南京传奇生物科技有限公司 |
靶向cd47的抗体及其用途
|
|
AU2023409398A1
(en)
|
2022-12-22 |
2025-06-05 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
IL321674A
(en)
*
|
2022-12-29 |
2025-08-01 |
Shanghai Henlius Biotech Inc |
Anti-cd47 antibodies and methods of use
|
|
AU2024252725A1
(en)
|
2023-04-11 |
2025-11-06 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
CR20250446A
(es)
|
2023-04-21 |
2025-12-02 |
Gilead Sciences Inc |
Inhibidores de prmt5 y usos de los mismos
|
|
AU2024306338A1
(en)
|
2023-06-30 |
2026-01-08 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
KR20260046403A
(ko)
|
2023-07-26 |
2026-04-07 |
길리애드 사이언시즈, 인코포레이티드 |
Parp7 저해제
|
|
CN121620513A
(zh)
|
2023-07-26 |
2026-03-06 |
吉利德科学公司 |
Parp7抑制剂
|
|
US20250109147A1
(en)
|
2023-09-08 |
2025-04-03 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250101042A1
(en)
|
2023-09-08 |
2025-03-27 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250154172A1
(en)
|
2023-11-03 |
2025-05-15 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025245003A1
(en)
|
2024-05-21 |
2025-11-27 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
US20260098049A1
(en)
|
2024-08-12 |
2026-04-09 |
Gilead Sciences, Inc. |
Kras modulating compounds
|